Recent events
Recent events tied to this brand in public sources.
Back to profile6 entries
2021
Parexel appoints Stephen Pyke as executive vice president of clinical data and digital services
Parexel announced Stephen Pyke’s appointment as executive vice president of clinical data and digital services, a newly created position.
2021
EQT and Goldman Sachs agree to acquire Parexel for $8.5 billion
Parexel agreed to be acquired for $8.5 billion by EQT and the private equity business within Goldman Sachs Asset Management. The definitive agreement remains subject to compliance conditions and other customary factors.
2021
EQT and Goldman Sachs agree to acquire Parexel
Parexel announced a definitive agreement to be acquired by the EQT IX fund and the private equity business within Goldman Sachs Asset Management from Pamplona Capital Management for $8.5 billion. The transaction is subject to customary conditions, including applicable regulatory approvals.
2020
Parexel launches COVID-19 real-world evidence platform
Parexel announced the launch of its #KeepingPatientsFirst integrated Real-World Evidence research platform, powered by Microsoft Azure, to collate COVID-19 evidence and provide insights on treatments and outcomes.
2020
ExecuPharm discloses ransomware attack and data theft
ExecuPharm disclosed that ransomware attackers encrypted its servers and stole corporate and employee data. It said an investigation found that attackers may have accessed or shared personal information relating to its personnel and Parexel personnel; the article states that the incident occurred on March 13.
2019
Datavant and Parexel announce strategic partnership
Datavant announced a multi-year strategic partnership with Parexel. Parexel will roll out Datavant technology as the default workflow for all its clinical trials, connecting clinical trial data with real-world evidence.